the aid library

LIST OPTIONS

Filter

4642

Sort by:

Direction:

Download (1865)

View PDF (3435)

Guidelines for the Management of Snake-bites. 2nd edition
recommended

Word Health Organization Regional Office of South-East Asia Word Health Organization Regional Office of South-East Asia (2016) C_WHO

Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortal... more

Download (1505)

View PDF (2412)

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended

World Health Organization (2015) C_WHO

The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n... more

Download (154)

View PDF (268)

The global climate in 2015–2019

World Meteorological Organization (2019) CC

Compared to the previous five-year assessment period 2011–2015, the current five-year period 2015–2019 has seen a continued increase in carbon dioxide (CO2 ) emissions and an accelerated increase in the atmospheric concentration of major greenhouse gases (GHGs), with growth rates nearly 20% high... more

Download (897)

View PDF (1648)

Package of Essential Noncommunicable (PEN) disease interventions for primary health care in low-resource settings

World Health Organization WHO (2013) CC

Effective implementation of WHO PEN, combined with other very cost effective population-wide interventions, will help even resource constrained settings to attain the global voluntary targets related to reduction of premature mortality and preventionof heart attacks and strokes.

Download (477)

View PDF (1262)

Vaccination in Acute Humanitarian Emergencies - A Framework for Decision Making
recommended

World Health Organization (2018) CC

Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health ... more

Download (291)

View PDF (468)

Arsenic Mitigation in Bangladesh

United Nations Children’s Fund (UNICEF) (2010)

Arsenic contaminated tube well water was first detected in Bangladesh in early 1990s. The arsenic comes from naturally arsenic-rich material delivered by the region's river systems, deposited over many years to make up the land of Bangladesh. Arsenic contamination is not caused by tube wells, or by ... more

Download (265)

View PDF (347)

The Socio-Economic Impact of People Living with HIV at the Household Level in Myanmar

Cercone, James; Pinder, Étoile; Pothuis, Michal et al. The Republic of the Union of Myanmar, Ministry of Health and Sports; UNDP (2016) C1

The study collected data on the impact of HIV-related diseases on income, revenues, economic dependency, consumption, education, health, food security, stigma, discrimination, quality of life, and migration. The study also assessed people living with chronic diseases in order to compare the impact o... more

Download (233)

View PDF (332)

Trends and Inequalities in Young Child Nutrition in Rwanda: Further Analysis of the 2014-15 Demographic and Health Survey

Yourkavitch, Jennifer Rockville, Maryland, USA: ICF (2018) C2

DHS Further Analysis Reports No. 109 - This report documents trends in key child nutrition indicators in Rwanda. Data from the Demographic and Health Surveys (DHS) in 2005, 2010, and 2014-15 were analyzed, disaggregated by selected equity-related variables, and tested for trends. Over the survey per... more

Download (309)

View PDF (177)

Care for Mental Health Conditions in Jamaica: The Case for Investment. Evaluating the Return on Investment of Scaling Up Treatment for Depression, Anxiety, and Psychosis

Pan American Health Organisation PAHO (2020) C_WHO

Mental health is critical to personal well-being, interpersonal relationships, and successful contributions to society. Mental health conditions consequently impose a high burden not only on individuals, families and society, but also on economies. In Jamaica, mental health conditions are highly pre... more

Download (87)

View PDF (110)

Dietary salt intake survey in the Republic of Moldova, 2016

World Health OrganizationEurope (2018) C_WHO

High salt consumption is an important determinant of high blood pressure and reducing it would improve health outcomes by lowering cardiovascular disease and therefore death rates. Reducing salt intake has been identified as one of the most effective public health measures and is one of the leading ... more

Download (153)

View PDF (168)

Guide for clinical case management and infection prevention and control during a measles outbreak

World Health Organization WHO (2020) C_WHO

Guide for clinical case management and infection prevention and control during ameasles outbreak. This guide has been developed to reduce the high morbidity and mortality seen in some of the current outbreaks of measles. This short guide outlines practical clinical care interventions and is derived ... more

Download (210)

View PDF (249)

Myths & COVID-19 Vaccinations
recommended

Mauder, S.; and P. Reijer (2021) CC

Issue Brief no. 16. 20 Sept 2021. Many studies have shown the effectiveness of vaccination against COVID-19 and that it protects against severe illness. A high vaccination rate is needed to combat the pandemic worldwide. Due to misinformation and myths, there is still a great hesitancy to vaccina... more

Download (179)

View PDF (386)

Addition of HIV self-test kits to partner notification services to increase HIV testing of male partners of pregnant women in Zambia

Mutale W.; K. Freeborn; L. A Graybill; et al. Lancet (2021) CC

Testing men for HIV during their partner’s pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative ... more

Download (83)

View PDF (122)

STEPS: prevalence of noncommunicable disease risk factors in the Republic of Azerbaijan 2017

World Health Organization WHO, Regional Office of Europe (2021) CC

Noncommunicable diseases (‎NCDs)‎ are the principal cause of morbidity, disability and premature mortality in Azerbaijan. The most effective way to reduce the NCD burden is to prevent NCD development, by addressing thebehavioural risk factors underlying NCDs at the population and individual leve... more

Download (172)

View PDF (147)

A Roadmap to combat postpartum haemorrhage between 2023 and 2030

World Health Organization WHO (2023) C_WHO

WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths. Despite being preventable and treatable, PPH results in around 70 000 de... more

Download (245)

View PDF (329)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (8)

View PDF (12)

Guidelines for the prevention, management and care of diabetes mellitus

World Health Organization WHO (2006) C_WHO

Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ... more

Download (17)

View PDF (24)

WHO package of essential noncommunicable (PEN) disease interventions for primary health care

World Health Organization (WHO) World Health Organization (WHO) (2020) C_WHO

The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases (NCDs) such as cardiovascular diseases, diabetes, chronic respiratory diseases, and cancers. Designed ... more

Download (15)

View PDF (15)

Health Technology MANUAL: Improving the Integrated Management of Chronic Diseases at the First Level of Health Care Services

Pan American Health Organization PAHO; World Health Organization WHO (2017) C_WHO

Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,... more

Download (23)

View PDF (11)

Issue Brief Marburg virus disease (MVD)
recommended

The MEDBOX Team (2024) CC

Issue Brief No. 40 provides healthcare professionals with the most relevant treatment guidelines, prevention measures and training material on MVD

Guidelines for the Management of Snake-bites. 2nd edition recommended

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection recommended

Vaccination in Acute Humanitarian Emergencies - A Framework for Decision Making recommended

Myths & COVID-19 Vaccinations recommended

Issue Brief Marburg virus disease (MVD) recommended

Guidelines for the Management of Snake-bites. 2nd edition
recommended

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended

Vaccination in Acute Humanitarian Emergencies - A Framework for Decision Making
recommended

Myths & COVID-19 Vaccinations
recommended

Issue Brief Marburg virus disease (MVD)
recommended